| Literature DB >> 34305407 |
Chang Liu1, Xuan Liu2, Xiaowei Li2.
Abstract
INTRODUCTION: Alcohol-induced osteonecrosis of the femoral head (ONFH), a progressive disease, is caused by excessive drinking and genetic factors. Currently, it remains to represent a significant challenge. The association between alcohol-induced ONFH and RAB40C gene polymorphisms may provide a direction for the mechanism of alcoholic ONFH.Entities:
Keywords: RAB40C; alcohol-induced ONFH; single nucleotide polymorphisms
Year: 2021 PMID: 34305407 PMCID: PMC8296705 DOI: 10.2147/IJGM.S316481
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Comparison of Clinical Data in Case and Control Groups
| Characteristic | Case | Control | |
|---|---|---|---|
| Number | 201 | 201 | |
| Age(years, Mean ± SD) | 42.68 ± 12.88 | 42.87 ± 13.27 | 0.888a |
| BMI (kg/m2, Mean ± SD) | 21.15 ± 2.70 | 21.33 ± 2.87 | 0.383a |
| Drinking | 0.688b | ||
| Yes | 199(99%) | 199(99%) | |
| Deletion | 2(1%) | 2(1%) | |
| Smoking | 0.527b | ||
| No | 20(10%) | 25(12.4%) | |
| Yes | 179(90%) | 176(87.6%) | |
| Hip lesions | |||
| Unilateral | 44 (22%) | ||
| Bilateral | 157 (78%) | ||
| Clinical stages | |||
| I+II | 54 (27%) | ||
| III+IV | 147 (73%) |
Notes: aIndependent samples t test; bPearson Chi-squared test. p < 0.05 indicates statistical significance.
Abbreviation: SD, standard deviation.
Basic Information of the Three SNPs in This Study
| SNP ID | Gene | Chr | Position | Role | Alleles A/B | MAF | HWE | OR (95% CI) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Case | Control | |||||||||
| Rs4984677 | 16p13.3 | 621,682 | Intronic | A/G | 0.392 | 0.356 | 1.000 | 1.17 (0.88–1.56) | 0.290 | |
| Rs62030917 | 16p13.3 | 622,040 | Intronic | G/A | 0.295 | 0.221 | 0.218 | 1.47 (1.07–2.02) | 0.017* | |
| Rs2269556 | 16p13.3 | 625,215 | UTR3 | G/A | 0.413 | 0.381 | 0.767 | 1.14 (0.86–1.52) | 0.356 | |
Notes: aPearson Chi-squared test; *p< 0.05 indicates statistical significance.
Abbreviations: SNP, single nucleotide polymorphism; Chr, chromosome; Alleles A/B, Minor/Major alleles; HWE, Hardy Weinberg equilibrium; MAF, minor allele frequency; OR, odds ratio; 95% CI, 95% confidence interval.
Association Analysis Between SNPs and Alcohol-Induced ONFH Risk
| SNP ID | Model | Genotype | Case | Control | Without Adjusted | Adjusted | ||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||||||
| rs4984677 | Co-dominant | G/G | 75 (37.69%) | 83 (41.29%) | 1 | 1 | ||
| A/G | 92 (46.23%) | 93 (46.27%) | 1.10 (0.72–1.67) | 0.676 | 1.10 (0.72–1.67) | 0.677 | ||
| A/A | 32 (16.08%) | 25 (12.44%) | 1.42 (0.77–2.61) | 0.263 | 1.42 (0.77–2.61) | 0.263 | ||
| Dominant | G/G | 75 (37.69%) | 83 (41.29%) | 1 | 1 | |||
| A/G-A/A | 124 (62.31%) | 118 (58.71%) | 1.16 (0.78–1.74) | 0.461 | 1.16 (0.78–1.74) | 0.461 | ||
| Recessive | G/G-A/G | 167 (83.92%) | 176 (87.56%) | 1 | 1 | |||
| A/A | 32 (16.08%) | 25 (12.44%) | 1.35 (0.77–2.37) | 0.299 | 1.35 (0.77–2.37) | 0.299 | ||
| Log-additive | --- | --- | --- | 1.17 (0.88–1.55) | 0.293 | 1.17 (0.88–1.55) | 0.293 | |
| Rs62030917 | Co-dominant | A/A | 104 (52%) | 125 (62.19%) | 1 | 1 | ||
| G/A | 74 (37%) | 63 (31.34%) | 1.41 (0.92–2.16) | 0.112 | 1.41 (0.92–2.16) | 0.112 | ||
| G/G | 22 (11%) | 13 (6.47%) | 2.03 (0.98–4.24) | 0.058 | 2.04 (0.98–4.24) | 0.058 | ||
| Dominant | A/A | 104(52%) | 125(62.19%) | 1 | 1 | |||
| G/A-G/G | 96(48%) | 76(37.81%) | 1.52 (1.02–2.26) | 0.039* | 1.52 (1.02–2.26) | 0.039* | ||
| Recessive | A/A-G/A | 178(89%) | 188(93.53%) | 1 | 1 | |||
| G/G | 22(11%) | 13(6.47%) | 1.79 (0.87–3.66) | 0.112 | 1.79 (0.87–3.66) | 0.112 | ||
| Log-additive | --- | --- | --- | 1.42 (1.05–1.93) | 0.024* | 1.42 (1.05–1.93) | 0.025* | |
| Rs2269556 | Co-dominant | A/A | 72(36%) | 78(38.8%) | 1 | 1 | ||
| G/A | 91(45.5%) | 93(46.27%) | 1.06 (0.69–1.63) | 0.791 | 1.06 (0.69–1.63) | 0.792 | ||
| G/G | 37(18.4%) | 30(14.93%) | 1.34 (0.75–2.38) | 0.326 | 1.34 (0.75–2.38) | 0.327 | ||
| Dominant | A/A | 72(36%) | 78(38.81%) | 1 | 1 | |||
| G/A-G/G | 128(64%) | 123(61.19%) | 1.13 (0.75–1.69) | 0.562 | 1.13 (0.75–1.69) | 0.563 | ||
| Recessive | A/A-G/A | 163(81.5%) | 171(85.07%) | 1 | 1 | |||
| G/G | 37(18.5%) | 30(14.93%) | 1.29 (0.76–2.19) | 0.338 | 1.29 (0.76–2.19) | 0.339 | ||
| Log-additive | --- | --- | --- | 1.14 (0.86–1.50) | 0.366 | 1.14 (0.86–1.50) | 0.367 | |
Notes: *p < 0.05 indicates statistical significance.
Abbreviations: SNP, single nucleotide polymorphism; OR, odds ratio; 95% CI, 95% confidence interval.
Correlation Analysis of Rs62030917, Rs2269556 and Alcohol-Induced ONFH After Stratificated by Age and Hip Lesions in Different Genetic Models
| SNP | Model | Genotype | ≤42 | >42 | Unilateral | Bilateral | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR(95% CI) | OR(95% CI) | OR(95% CI) | OR(95% CI) | |||||||
| Rs62030917 | Co-dominant | A/A | 1 | 1 | 1 | 1 | ||||
| G/A | 1.24 (0.67–2.28) | 0.494 | 1.61 (0.88–2.91) | 0.120 | 2.20 (1.08–4.45) | 0.036* | 1.25 (0.79–1.97) | 0.343 | ||
| G/G | 3.00 (1.08–8.30) | 0.035* | 1.21 (0.40–3.65) | 0.742 | 3.20 (1.08–9.48) | 0.029* | 1.79 (0.82–3.92) | 0.144 | ||
| Dominant | A/A | 1 | 1 | 1 | 1 | |||||
| G/A-G/G | 1.51 (0.86–2.66) | 0.152 | 1.53 (0.87–2.68) | 0.139 | 2.37 (1.22–4.61) | 0.011* | 1.34 (0.88–2.05) | 0.178 | ||
| Recessive | A/A-G/A | 1 | 1 | 1 | 1 | |||||
| G/G | 2.77 (1.03–7.47) | 0.044* | 1.01 (0.34–3.00) | 0.984 | 2.28 (0.82–6.38) | 0.116 | 1.65 (0.77–3.55) | 0.197 | ||
| Log-additive | --- | 1.53 (1.00–2.33) | 0.048 | 1.31 (0.84–2.04) | 0.239 | 1.90 (1.18–3.08) | 0.009* | 1.30 (0.94–1.80) | 0.114 | |
| Alleles | G/A | 1.62 (1.04–2.54) | 0.033* | 1.33 (0.84–2.09) | 0.224 | 2.01 (1.23–3.29) | 0.005* | 1.34 (0.95–1.88) | 0.095 | |
| Rs2269556 | Co-dominant | A/A | 1 | 1 | 1 | 1 | ||||
| G/A | 0.94 (0.50–1.73) | 0.831 | 1.20 (0.65–2.20) | 0.565 | 1.59 (0.72–3.51) | 0.247 | 0.96 (0.61–1.52) | 0.870 | ||
| G/G | 1.19 (0.53–2.66) | 0.671 | 1.51 (0.66–3.48) | 0.333 | 2.83 (1.13–7.10) | 0.027* | 1.07 (0.57–2.00) | 0.841 | ||
| Dominant | A/A | 1 | 1 | 1 | 1 | |||||
| G/A-G/G | 1.00 (0.56–1.78) | 0.995 | 1.27 (0.71–2.25) | 0.419 | 1.90 (0.90–3.97) | 0.090 | 0.99 (0.64–1.52) | 0.955 | ||
| Recessive | A/A-G/A | 1 | 1 | 1.00 | 1 | |||||
| G/G | 1.23 (0.59–2.57) | 0.574 | 1.37 (0.64–2.92) | 0.422 | 2.13 (0.99–4.60) | 0.053 | 1.09 (0.61–1.94) | 0.774 | ||
| Log-additive | --- | 1.06 (0.72–1.57) | 0.762 | 1.22 (0.82–1.82) | 0.325 | 1.68 (1.06 −2.67) | 0.028* | 1.02 (0.75–1.37) | 0.913 | |
| Alleles | G/A | 1.07 (0.71–1.59) | 0.758 | 1.22 (0.82–1.82) | 0.320 | 1.70 (1.07–2.71) | 0.023* | 1.02 (0.75–1.38) | 0.913 | |
Notes: *p < 0.05 indicates statistical significance.
Abbreviations: SNP, single nucleotide polymorphism; OR, odds ratio, 95% CI, 95% confidence interval.
Figure 1In patients with unilateral lesions, LD plots containing three SNPs from RAB40C.
Figure 2In patients older than 42 years old, LD plots containing three SNPs from RAB40C.
Comparative Analysis of Plasma Lipoprotein and Lipid Levels in Carrier with Different Genotypes of Rs4984677, Rs62030917 and Rs2269556
| SNP | TC (mmol/L) | TG (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) | PLT (109/L) | |
|---|---|---|---|---|---|---|
| Rs4984677 | AA(n=32) | 4.70± 1.05 | 1.69± 0.85 | 1.03± 0.25 | 2.91± 1.06 | 228.53±71.16 |
| AG(n=92) | 4.74± 0.91 | 1.88± 1.20 | 1.06± 0.24 | 2.77± 0.84 | 229.51±53.58 | |
| GG(n=75) | 4.50± 0.86 | 1.99± 1.53 | 1.02± 0.22 | 2.58± 0.71 | 230.13±60.63 | |
| 0.244 | 0.551 | 0.366 | 0.120 | 0.964 | ||
| Rs62030917 | AA(n=104) | 4.59± 0.89 | 2.02± 1.42 | 1.03± 0.23 | 2.65± 0.84 | 230.94±62.13 |
| GA(n=74) | 4.73± 0.92 | 1.73± 1.17 | 1.08± 0.25 | 2.81± 0.78 | 227.58±53.90 | |
| GG(n=22) | 4.63± 1.07 | 1.85± 0.88 | 0.99± 0.24 | 2.82± 1.13 | 232.41±75.66 | |
| 0.611 | 0.331 | 0.225 | 0.387 | 0.916 | ||
| Rs2269556 | AA(n=72) | 4.52± 0.88 | 2.04± 1.55 | 1.02± 0.22 | 2.55± 0.71 | 228.54±66.49 |
| GA(n=91) | 4.72± 0.89 | 1.81± 1.20 | 1.07± 0.24 | 2.78± 0.83 | 231.65±52.81 | |
| GG(n=37) | 4.76± 1.06 | 1.79± 0.85 | 1.03± 0.26 | 2.95± 1.08 | 227.43±67.48 | |
| 0.296 | 0.472 | 0.396 | 0.047* | 0.918 |
Notes: *p < 0.05 indicates statistical significance.
Abbreviations: TC, Total cholesterol; TG, Triglycerides; LDL-C, Low-density lipoprotein-cholesterol; HDL-C, High-density lipoprotein-cholesterol; ApoA1, Apolipoprotein A1; ApoB, Apolipoprotein B; PLT, platelet count.